Skip to content
★ Sign in to follow
IB

Iris Biotechnologies Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Chin Simon, was filed 30 Dec 2015.

Iris Biotechnologies Inc: what insiders have been doing

Iris Biotechnologies Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Iris Biotechnologies Inc. The previous disclosure was published on 21 December 2017.

Over the whole record (from 2008), the tally stands at 68 purchases and 26 sales.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
115
Thresholds
n/a
Buy Volume
€48,326
68 ops. · all time
Sell Volume
€32,586
26 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2015

FY ended December 2015 · cache

Income statement
Net income-1M
Last declaration on 21 December 2017
Declarations115 total
  • ●
    Chief Executive OfficerExecutives
    31,248 USD23SEC
    390,600 shares@ US$0.085.7% of flowCommon StockSEC:0001554795-17-000425:0
  • ●
    Chief Executive OfficerExecutives
    41,667 USD23SEC
    347,222 shares@ US$0.127.7% of flowCommon StockSEC:0001554795-17-000415:0
  • ●
    Chief Executive OfficerExecutives
    31,250 USD23SEC
    312,500 shares@ US$0.105.7% of flowCommon StockSEC:0001554795-17-000363:0
  • ●
    Chief Executive OfficerExecutives
    41,667 USD23SEC
    416,670 shares@ US$0.107.7% of flowCommon StockSEC:0001554795-17-000328:0
  • ●
    Chief Executive OfficerExecutives
    41,667 USD23SEC
    198,413 shares@ US$0.218.0% of flowCommon StockSEC:0001554795-17-000239:0
  • ●
    Chief Executive OfficerExecutives
    62,500 USD23SEC
    339,674 shares@ US$0.18412.8% of flowCommon StockSEC:0001554795-17-000091:0
  • ●
    Chief Executive OfficerExecutives
    41,665 USD23SEC
    320,500 shares@ US$0.138.6% of flowCommon StockSEC:0001554795-16-001000:0
  • ▼
    Chief Executive OfficerExecutives
    631 USD22SEC
    5,650 shares@ US$0.11160.1% of flowCommon StockSEC:0001554795-16-000968:2
  • ▼
    Chief Executive OfficerExecutives
    1,100 USD22SEC
    10,000 shares@ US$0.110.2% of flowCommon StockSEC:0001554795-16-000968:3
  • ▼
    Chief Executive OfficerExecutives
    300 USD22SEC
    2,500 shares@ US$0.120.1% of flowCommon StockSEC:0001554795-16-000968:4
  • ▼
    Chief Executive OfficerExecutives
    2,750 USD22SEC
    27,500 shares@ US$0.100.6% of flowCommon StockSEC:0001554795-16-000968:5
  • ▼
    Chief Executive OfficerExecutives
    950 USD22SEC
    11,881 shares@ US$0.080.2% of flowCommon StockSEC:0001554795-16-000968:6
  • ▼
    Chief Executive OfficerExecutives
    910 USD22SEC
    10,000 shares@ US$0.0910.2% of flowCommon StockSEC:0001554795-16-000968:7
  • ▼
    Chief Executive OfficerExecutives
    285 USD22SEC
    2,500 shares@ US$0.1140.1% of flowCommon StockSEC:0001554795-16-000968:8
  • ▼
    Chief Executive OfficerExecutives
    900 USD22SEC
    10,000 shares@ US$0.090.2% of flowCommon StockSEC:0001554795-16-000968:9
  • ▼
    Chief Executive OfficerExecutives
    1,140 USD22SEC
    10,000 shares@ US$0.1140.2% of flowCommon StockSEC:0001554795-16-000968:10
  • ▼
    Chief Executive OfficerExecutives
    900 USD22SEC
    10,000 shares@ US$0.090.2% of flowCommon StockSEC:0001554795-16-000968:11
  • ▼
    Chief Executive OfficerExecutives
    123 USD22SEC
    1,250 shares@ US$0.0980.0% of flowCommon StockSEC:0001554795-16-000968:12
  • ▼
    Chief Executive OfficerExecutives
    1,600 USD22SEC
    20,000 shares@ US$0.080.3% of flowCommon StockSEC:0001554795-16-000968:13
  • ▼
    Chief Executive OfficerExecutives
    190 USD22SEC
    1,250 shares@ US$0.1520.0% of flowCommon StockSEC:0001554795-16-000968:0
  • ▼
    Chief Executive OfficerExecutives
    2,610 USD22SEC
    21,750 shares@ US$0.120.5% of flowCommon StockSEC:0001554795-16-000968:1
  • ●
    Chief Executive OfficerExecutives
    83,333 USD24SEC
    416,667 shares@ US$0.2016.3% of flowCommon StockSEC:0001554795-16-000897:0
  • ●
    Chief Executive OfficerExecutives
    0SEC
    50,000 shares0Common StockSEC:0001554795-16-000762:0
  • ●
    Chief Executive OfficerExecutives
    125,000 USD24SEC
    1,041,667 shares@ US$0.1224.6% of flowCommon StockSEC:0001554795-16-000762:1
  • ▲
    Chief Executive OfficerExecutives
    22 USD0SEC
    100 shares@ US$0.2249Common StockSEC:0001554795-15-000507:0
    Canonical exit: 14 Mar 2016 (T+90)

25 of 115 declarations

About Iris Biotechnologies Inc

Iris Biotechnologies Inc is a biotechnology company focused on developing innovative solutions. It is listed on NASDAQ under the ticker XNAS.